Molecular quantification for quality control of Jinqian Baihuashe in Jinlong Capsule
10.16438/j.0513-4870.2022-1437
- VernacularTitle:金龙胶囊中金钱白花蛇的分子质量控制
- Author:
Hui LIN
;
Chan LI
;
Zhi CHAO
- Publication Type:Research Article
- Keywords:
Jinqian Baihu She;
italic>Bungarus multicinctus;
Jinlong capsule;
molecular quantification;
quality control;
real time fluorescent quantitative PCR
- From:
Acta Pharmaceutica Sinica
2023;58(9):2771-2776
- CountryChina
- Language:Chinese
-
Abstract:
The quality control of Chinese patent medicines containing animal-derived crude drugs is relatively difficult, because the effective constituents of most animal-derived crude drugs remain unknown. Even if there are relevant methods, they are usually qualitative, and quantitative indicators are either lacking or have poor specificity. This paper has proposed to use molecular quantitative technology to control the quality of Chinese patent medicines containing animal-derived crude drugs. In this study, a molecular quantitative method based on fluorescence quantitative PCR was established for the determination of Jinqian Baihua She in Jinlong Capsule. The method has good specificity, sensitivity, and repeatability. There is a good linear relationship between the content of DNA fragments and the CT (cycle threshold) value. The content of the Bungarus multicinctus-specific fragment in Jinlong Capsule is 24.1-46.6 IU·mg-1. It is suggested that the content of the specific fragment of Jinqian Baihua She should not be less than 19.3 IU·mg-1 as one of the quality control criteria of Jinlong Capsule. The study can provide a reference for the quality control of Chinese patent medicines containing animal-derived crude drugs.
